An observational, cohort assessing the performance of idarucizumab as antidote of dabigatran
Latest Information Update: 08 Oct 2020
At a glance
- Drugs Idarucizumab (Primary)
- Indications Blood coagulation disorders
- Focus Therapeutic Use
- 08 Oct 2020 New trial record